<DOC>
	<DOCNO>NCT00698230</DOCNO>
	<brief_summary>Determine effect treatment INCB013739 administer 'add-on ' metformin therapy type 2 diabetic subject safety tolerability glycemic control .</brief_summary>
	<brief_title>Safety Efficacy INCB013739 Plus Metformin Compared Metformin Alone Glycemic Control Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Established diagnosis Type 2 Diabetes Stable dose metformin 8 week Subjects Addison 's disease Cushing 's Syndrome Type 1 diabetes mellitus secondary form diabetes Subjects uncontrolled thyroid disease History renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>